How Cigna’s AI chief is investing in the technology to cut costs and address some of health care’s biggest problems
Katya Andresen says AI can make healthcare more conversational, proactive, and personal for Cigna's 185 million customers.
At a glance
- $CI today+1.06%last $300.16
- Vs industry peers−2.12 pts6-peer median +3.18% · far behind
- Since Aug 26+8.10%from the first trade after the story
- 52-week range5.6% below high$257.85 – $318.05
- Last reported profit$1.44Bquarter to Sep 30, 2026 · 10-Q
- Coverage1 this week1 in 30 days · too few stories to call a pace
Nothing reported about Cigna across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Options price an average move of ±6.6% by Dec 18 — the at-the-money straddle, the typical size of the move; the bands are one standard deviation.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: Healthcare setbacks hit hardest at single-product companies — one failed trial can be most of the story.
- How the stock is trading: $CI +1.06% in the latest session.
- Timing: It was published while New York was trading, so the day's move may already include the first reaction.
Where the stock stands
The Cigna ($CI) added 1.06% to $300.16 in the latest session. Over the past month it is up 0.6%. That leaves it 5.6% below its 52-week high of $318.05 and 16% above its low of $257.85. The high sits 23% above the low, a moderate range for a year.
What the filings say
In its latest report (10-Q, filed Nov 5, 2026), $CI earned $1.44B over the quarter to Sep 30, 2026 on revenue of $73.68B (+2.8% QoQ). Operations brought in $3.28B of cash over the nine months to Sep 30, 2026. Total liabilities were $113.92B against $6.19B of cash on Sep 30, 2026. Its most recent filings before this story: 10-Q on Jul 30, 2026, 8-K on Jul 30, 2026. Figures are as filed with the SEC; the $CI page has the full statements.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed one newer story on The Cigna, published this week. It reads bullish.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
Coming up
$CI earnings in 79 days, a date set before this story ran.
What to watch next
For the company's side of it, read its latest SEC filings on the $CI page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. To run the numbers yourself, ask Wook AI above about $CI: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Fortune published this on August 26, 2026. $CI has moved +8.10% ($277.67 to $300.16). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
